Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Eline Naert

Work address: C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent
Email: Eline.Naert@UGent.be

Show Sort by

Add to list
- Journal Article
Clinical decision-making in older patients with cancer: a cross-sectional single-centre study to assess the impact of clinical judgement and patient preferences

Annelies Deldycke, Hannelore Denys (UGent) , Alexander Decruyenaere (UGent) , Anja Velghe (UGent) and Eline Naert (UGent)

(2022) Acta Clinica Belgica. p.1-9
Add to list
2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, Ann M.T. van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, et al.

(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. In International Journal of Gynecological Cancer 32(Supplement 2). p.A187-A188
Add to list
- Journal Article
- A1
- open access
CHEK2 mutations and papillary thyroid cancer : correlation or coincidence?

Koen Kortbeek, Robin de Putter (UGent) and Eline Naert (UGent)

(2022) HEREDITARY CANCER IN CLINICAL PRACTICE. 20(1).
Add to list
- Journal Article
- A1
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens (UGent) , Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, et al.

(2022) CANCER IMMUNOLOGY IMMUNOTHERAPY.
Add to list
- Journal Article
- A1
- open access
Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study

Emiel De Jaeghere (UGent) , Heini Kanervo (UGent) , Roos Colman (UGent) , Wim Schrauwen (UGent) , Paulien West (UGent) , Nele Vandemaele (UGent) , Aglaja De Pauw (UGent) , Celine Jacobs (UGent) , Ingeborg Hilderson, Michael Saerens (UGent) , et al.

(2022) CANCERS. 14(4).
Add to list
- Journal Article
- A1
- open access
Safety of pre- or postoperative accelerated radiotherapy in 5 fractions : a randomized pilot trial

Vincent Vakaet (UGent) , Hans Vanhulle, Koen Van de Vijver (UGent) , Ingeborg Hilderson, Eline Naert (UGent) , Wilfried De Neve (UGent) , Jo Van Dorpe (UGent) , An Hendrix (UGent) , Menekse GOKER (UGent) , Herman Depypere (UGent) , et al.

(2022) BREAST. 62. p.10-15
Add to list
A clearer view on ovarian clear cell carcinoma

Aglaja De Pauw (UGent) , Eline Naert (UGent) , Koen Van de Vijver (UGent) , Philippe Tummers (UGent) , Katrien Vandecasteele (UGent) and Hannelore Denys (UGent)

(2022) ACTA CLINICA BELGICA.
Add to list
- Conference Paper
- C3
Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, Ann M.T. Van Nuffel, Lien Lippens (UGent) , An Hendrix (UGent) , P. Vuylsteke, S. Henry, X.B. Trinh, P.A. Van Dam, S. Aspeslagh, et al.

(2021) ANNALS OF ONCOLOGY. In Annals of Oncology 32(Supplement 7). p.S1449-S1450
Add to list
- Journal Article
- A1
- open access
Risk of thrombo-embolic events in ovarian cancer : does bevacizumab tilt the scale? A systematic review and meta-analysis

Michael Saerens (UGent) , Emiel De Jaeghere (UGent) , Heini Kanervo (UGent) , Nele Vandemaele (UGent) , Hannelore Denys (UGent) and Eline Naert (UGent)

(2021) CANCERS. 13(18).
Add to list
Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer

Emiel De Jaeghere (UGent) , Frederiek Laloo (UGent) , Lien Lippens (UGent) , Mieke Van Bockstal (UGent) , Kathia De Man (UGent) , Eline Naert (UGent) , Jo Van Dorpe (UGent) , Koen Van de Vijver (UGent) , Philippe Tummers (UGent) , Amin Makar (UGent) , et al.

(2020) GYNECOLOGIC ONCOLOGY. 159(2). p.335-343

1
2

Next →